Pavan Kumar Chintamaneni

Employment

• GITAM School of Pharmacy Assistant Professor
  2021 - Present
• Raghavendra Institute of Pharmaceutical Education Assistant Professor & Head
  2019 - 2021
• JSS COllege of Pharmacy, Ooty Senior Research Fellow (DBT-SRF)
  2015 - 2019
• Aditya College of Pharmacy Assistant Professor
  2012 - 2015

Education

• JSS College of Pharmacy Doctor of Philosophy (Faculty of Pharmacy)
  2016 - 2019
• GIET School of Pharmacy M. Pharmacy
  2009 - 2011
• Aditya College of Pharmacy B. Pharmacy
  2005 - 2009

Projects & Funding

Projects & funding information is unavailable.

Publications (36)

• Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review
  Pharmaceutics 2023 DOI: 10.3390/pharmaceutics15061593
  +Save
• Safety Assessment of a Standardized Polyherbal Formulation (Glubloc™): Acute Toxicity Study and 28-Day Repeated Dose Toxicological Studies
  2023 DOI: 10.1101/2023.09.13.557515
  +Save
• DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer
  Chemistry and Physics of Lipids 2021 DOI: 10.1016/j.chemphyslip.2020.105033
  +Save
• Polysorbate-80 surface modified nano-stearylamine BQCA conjugate for the management of Alzheimer's disease
  RSC Advances 2021 DOI: 10.1039/D1RA00049G
  +Save
• Chemometrics Assisted QuEChERS Extraction Method for the Residual Analysis of Organophosphate Insecticides: Application to Their Dissipation Kinetics in Open Field Ecosystem
  Analytical Chemistry Letters 2020 DOI: 10.1080/22297928.2021.1876575
  +Save
• Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson’s disease management
  Expert Opinion on Drug Delivery 2020 DOI: 10.1080/17425247.2020.1779218
  +Save
• Phenyl Boronic Acid-Modified Lipid Nanocarriers of Niclosamide for Targeting Triple-Negative Breast Cancer
  Nanomedicine 2020 DOI: 10.2217/nnm-2020-0003
  +Save
• Novel drug delivery systems of $β$2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson’s disease management
  Expert Opinion on Drug Delivery 2020
  +Save
• Phenyl boronic acid-modified lipid nanocarriers of niclosamide for targeting triple-negative breast cancer
  Nanomedicine 2020
  +Save
• Plausible role of combination of Chlorpromazine hydrochloride and Teicoplanin against COVID-19
  Medical hypotheses 2020
  +Save